Amlodipine Besylate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-836 -
Package NDC
69097-836-05 -
Package NDC
69097-836-15 -
Application number
ANDA077955 -
SPL ID
adb955ec-2369-441f-9db6-0a22bb5b2e7e -
SPL set ID
0c8d6b2f-3e4a-47a2-80e2-a34dcb337555 -
UNII
864V2Q084H -
RxCUI
197361 -
RxCUI
308135 -
RxCUI
308136
What the source publishes
- Labeler
- Cipla USA Inc.
- Active ingredients
- Amlodipine Besylate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Amlodipine Besylate",
"splId": "adb955ec-2369-441f-9db6-0a22bb5b2e7e",
"labels": [
{
"setId": "0c8d6b2f-3e4a-47a2-80e2-a34dcb337555",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c8d6b2f-3e4a-47a2-80e2-a34dcb337555",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c8d6b2f-3e4a-47a2-80e2-a34dcb337555"
}
],
"routes": [
"ORAL"
],
"labeler": "Cipla USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (69097-836-05)",
"package_ndc": "69097-836-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20160701"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (69097-836-15)",
"package_ndc": "69097-836-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20160701"
}
],
"productId": "69097-836_adb955ec-2369-441f-9db6-0a22bb5b2e7e",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "69097-836",
"deaSchedule": null,
"genericName": "Amlodipine Besylate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMLODIPINE BESYLATE",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA077955",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160701",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0369097836054",
"0369097838058",
"0369097837051"
],
"unii": [
"864V2Q084H"
],
"rxcui": [
"197361",
"308135",
"308136"
],
"spl_set_id": [
"0c8d6b2f-3e4a-47a2-80e2-a34dcb337555"
],
"manufacturer_name": [
"Cipla USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-836_adb955ec-2369-441f-9db6-0a22bb5b2e7e"